mAbxience and the entire Insud Pharma group have once again been rated “very good” in the 2017-2020 edition of the Spanish government’s Profarma Programme, thanks to our contribution to modernising the sector, our commitment to R&D and our clear focus on activities that add value.

The Programme is run by the Spanish Ministry of Economy, Industry and Competitiveness and the Ministry of Health, Social Services and Equality. It seeks to make Spain’s pharma industry more competitive, classifying and rating the companies in the sector based on the degree of excellence attained in a range of industrial, economic and innovation categories.

This strong rating is great motivation to keep developing and manufacturing new medications and to roll out further innovations using the latest technologies that ensure quality medicines are within everyone’s reach.

None of this would be possible without the incredible team at mAbxience and the entire Insud Pharma group, and our constant investment, year after year, in talent development.